GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » PensionAndRetirementBenefit

Artrya (ASX:AYA) PensionAndRetirementBenefit : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya PensionAndRetirementBenefit?

Artrya's PensionAndRetirementBenefit for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Artrya's quarterly PensionAndRetirementBenefit increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.01 Mil) but then declined from Jun. 2024 (A$0.01 Mil) to Dec. 2024 (A$0.00 Mil).

Artrya's annual PensionAndRetirementBenefit declined from Jun. 2022 (A$0.02 Mil) to Jun. 2023 (A$0.00 Mil) but then increased from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.01 Mil).


Artrya PensionAndRetirementBenefit Historical Data

The historical data trend for Artrya's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya PensionAndRetirementBenefit Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
PensionAndRetirementBenefit
- 0.02 - 0.01

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PensionAndRetirementBenefit Get a 7-Day Free Trial - - - 0.01 -

Artrya PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines